|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K2039/505 | (2013.01) |
| A61K 39/00 | (2006.01) | ||
| C07K 16/24 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/55 | (2013.01) | ||
| C07K2317/565 | (2013.01) | ||
| C07K2317/94 | (2013.01) | ||
| C07K 16/249 | (2013.01) | ||
| C07K2317/33 | (2013.01) | ||
| C07K2317/34 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 37/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Patento numeris | 3448419 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17733171.7 |
| Europos patento paraiškos padavimo data | 2017-04-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/030089 |
| Data | 2017-04-28 |
| (87) | Numeris | WO 2017/189983 |
| Data | 2017-11-02 |
| (30) | Numeris | Data | Šalis |
| 201662329327 P | 2016-04-29 | US | |
| 201662339709 P | 2016-05-20 | US | |
| 201762483669 P | 2017-04-10 | US |
| (72) |
GULLA, Stefano V. , US
HUARD, Christine , US
BUHLMANN, Janet Elizabeth , US
ALMAGRO, Juan Carlos , US
KODANGATTIL, Sreekumar R. , US
GREENBERG, Steven A. , US
LAVALLIE, Edward Roland , US
BENNETT, Eric M. , US
MOSYAK, Lidia , US
HALL, Jame Perry , US
COYLE, Anthony John , US
|
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
The Brigham and Women's Hospital, Inc. , 75 Francis Street, Boston, MA 02115, US |
| (54) | INTERFERON BETA ANTIBODIES AND USES THEREOF |
| INTERFERON BETA ANTIBODIES AND USES THEREOF |